Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medtech Industry Reacts To Biden’s Nomination Of ACA Defender Becerra To Lead HHS

AdvaMed, MDMA laud Becerra’s pick

Executive Summary

The president-elect on 7 December named nominees for his health team, including California attorney general Xavier Becerra for HHS secretary. Missing from the list is a nominee for FDA commissioner.

You may also be interested in...



ACA Champion Becerra Confirmed As HHS Chief

The former Congressman and California attorney general was confirmed with only one GOP vote. He’ll be integral to managing the pandemic as well as implementing the ACA and reimbursement policy.

HHS Secretary Nominee Becerra Could Face Tough Audience At Senate Confirmation Hearings

President Biden’s pick for HHS secretary, Xavier Becerra, is scheduled to face supporters and detractors at US Senate confirmation hearings next week.

One-Two Punch Of HHS Rules On Guidance Docs, Regs Will ‘Tie Hands’ Of Biden Admin: Expert

Two new rules put forward by the US HHS could have a chilling effect on future guidance documents and regulations drafted by the FDA and the 27 other agencies and offices the HHS oversees, a policy expert says. This and other stories topped our list of most-read US regulation, policy, quality control and compliance articles in December.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT143180

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel